Projects per year
Personal profile
Education
- 2005 Ph.D. (Anatomy and Cell Biology), Queen's University, Kingston, Ontario, Canada
- 1997 B.S.(Biochemistry), Queen's University, Kingston, Ontario, Canada
Experience
- 2019- Associate Professor, Graduate Institute of Biomedical Informatics, Taipei Medical University
-
2013- Associate Professor, The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2012-2013 Assistant Professor, The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2008-2012 Assoistant Professor, Department of Radiology, Taipei Medical University
- 2010 Visiting scholar to Dr. Andrew Kung’s lab at Dana Farber Cancer Institute
Research Interests
- Molecular Biology
- Preclinical mouse tumor models
- Small animal imaging
- Cancer stem cell research
- Translational medicine
URL
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 13 Finished
Study of Expression and Functional Mechanisms of Histamine N-Methyltransferase (HNMT) in Tumorigenesis and Correlation with Progression in Lung Cancer
Wang, L., Lee, W., Ho, Y. & Wu, T. A.
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
The Development and Preclinical Evaluation of a Theronostic Nanovehicle Drug for Treating Acute Myeloid Leukemia and Leukemia Stem Cells (I)
Yen, Y., Cheng, T. & Wu, T. A.
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
臨床前FGFR抑制劑對於抗藥性胰臟癌療效之評估
5/1/15 → 4/30/16
Project: C - Project of Alliance › t - Taipei Medical University Shuang Ho Hospital
探討LncRNA MALAT1 在惡性乳癌幹細胞生成之角色以及pterostilbene 對於透過抑制MALAT1而抑制乳癌幹細胞功能之研究
6/1/14 → 5/31/15
Project: C - Project of Alliance › t - Taipei Medical University Shuang Ho Hospital
探討樟芝萃取物antrocin在抑制大直腸癌細胞轉移的效用及機制
3/1/13 → 2/28/14
Project: C - Project of Alliance › n - Chi Mei Medical Center
Research Output
Ovatodiolide suppresses oral cancer malignancy by down-regulating exosomal mir-21/STAT3/β-catenin cargo and preventing oncogenic transformation of normal gingival fibroblasts
Chen, J. H., Wu, A. T. H., Bamodu, O. A., Yadav, V. K., Chao, T. Y., Tzeng, Y. M., Mukhopadhyay, D., Hsiao, M. & Lee, J. C., Jan 2020, In : Cancers. 12, 1, 56.Research output: Contribution to journal › Article
Open Access
Adjuvant therapy for high-risk stage ii or iii colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study
Chang, C. L., Yuan, K. S. P., Wu, A. T. H. & Wu, S. Y., Dec 2019, In : Cancers. 11, 12, 2003.Research output: Contribution to journal › Article
Open Access
A novel multi-target small molecule, LCC-09, inhibits stemness and therapy-resistant phenotypes of glioblastoma cells by increasing MIR-34a and deregulating the DRD4/AKT/MTOR signaling axis
Wen, Y. T., Wu, A. T., Bamodu, O. A., Wei, L., Lin, C. M., Yen, Y., Chao, T. Y., Mukhopadhyay, D., Hsiao, M. & Huang, H. S., Oct 1 2019, In : Cancers. 11, 10, 1442.Research output: Contribution to journal › Article
Open Access
Antrocin, a bioactive component from Antrodia cinnamomea, suppresses breast carcinogenesis and stemness via downregulation of β-catenin/Notch1/Akt signaling
Chen, J. H., T.H Wu, A., T.W Tzeng, D., Huang, C. C., Tzeng, Y. M. & Chao, T. Y., Jan 1 2019, In : Phytomedicine. 52, p. 70-78 9 p.Research output: Contribution to journal › Article
2
Citations
(Scopus)
Antrodia cinnamomea enhances chemo-sensitivity of 5-fu and suppresses colon tumorigenesis and cancer stemness via up-regulation of tumor suppressor miR-142-3p
Huang, Y. J., Yadav, V. K., Srivastava, P., Wu, A. T. H., Huynh, T. T., Wei, P. L., Huang, C. Y. F. & Huang, T. H., Aug 1 2019, In : Biomolecules. 9, 8, 306.Research output: Contribution to journal › Article
Open Access
1
Citation
(Scopus)